J. Lekieffre et al., EFFECTS OF 200-300 MG SR DILTIAZEM ON HEA RT-RATE - RETROSPECTIVE ANALYSIS OF 7 STUDIES CONDUCTED IN 2066 ANGINA OR HYPERTENSIVE PATIENTS, La Semaine des hopitaux de Paris, 73(5-6), 1997, pp. 141-147
The prognostic value of heart rate in cardiovascular disease has recen
tly been emphasized, The effect on survival of antihypertensive and an
tiischemic drugs may be partially related to their chronotropic effect
. This analysis aimed at assessing the effect on heart rate of 200 mg
and 300 mg sustained-release (SR) diltiazem once daily. A retrospectiv
e analysis was performed from 6 double blind studies in angina (n = 2)
or hypertension (n = 4) and one large open study in hypertension. The
se studies included 2066 patients of whom 1645 received SR diltiazem.
Heart rate was evaluated before and after 34 (7-42) days of treatment,
Mean decreases in resting heart rate ranged from -2.2 +/- 10.2 bpm to
-6.1 +/- 10.1 bpm according to SR diltiazem dosage and underlying dis
ease, Heart rate values at baseline and at predetermined levels of exe
rcise were significantly lower on SR diltiazem than on placebo, and ad
aptation of heart rate at exercise was maintained. A descriptive analy
sis on data in arterial hypertension also suggests that changes in res
ting heart rate were greater when baseline heart rate was elevated, In
conclusion, 200-300 mg SR diltiazem once daily has a mode-rate and co
ntrolled heart rate lowering effect. This is associated with good tole
rance and exercise performance and probably contributes to the cardiop
rotective effects of diltiazem.